Navigation Links
FDA panel refuses anti-viral cold remedy

An advisory panel voted unanimously against recommending FDA approval for the first antiviral cold medication, dashing company hopes of having the drug on the market in time for this year's cold season. The FDA's Antiviral Drugs Advisory Committee cited safety concerns of the drug pleconaril, which it said were not balanced by the drug's "modest" benefits in treating an illness that is not life-threatening. //

Pleconaril prevents the infection of cells by a group of germs called picornaviruses, which are the most common cause of the common cold. In clinical studies, the drug eased symptoms and cut the duration of colds by about a day. One concern is that pleconaril tablets must be taken within 24 hours of the first symptoms, making the drug's real-life usefulness questionable. Because colds are not serious illnesses, it's unlikely that patients would see a doctor within a day of the first symptoms.

The drug's developer, ViroPharma and marketing partner Aventis Pharmaceuticals, had hoped to have it on the market in the earliest possible under the brand name Picovir. Mark McKinlay, vice president of research and development for Viro Pharma, says the drug isn't dead. The company plans to meet with the FDA in coming weeks to see what steps they need to take to get approval.
'"/>




Page: 1

Related medicine news :

1. Expert panel confident of making AIIMS fully autonomous
2. Increased demand for Bird flu anti-viral drug world wide
3. A remedy to overcome dandruff
4. A remedy to lessen fatigue
5. New remedy for those suffering from Crohns disease
6. Now art comes as a remedy and aid to GPs.
7. Simple remedy to prevent DVT: Eat 6 Tomatoes!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... NEW YORK (PRWEB) , ... May 05, 2016 , ... ... and swimming safety – today announced a new partnership to reach nearly 1 million ... can happen in an instant and is the leading cause of accidental death in ...
(Date:5/5/2016)... WA (PRWEB) , ... May 05, 2016 , ... ... user experience, adapted to people’s every day living patterns, Amerec, a Seattle-based steam ... computer and smart phone app. , The user interface of the app, developed ...
(Date:5/5/2016)... (NEW YORK, New York) , ... (PRWEB) May 05, 2016 , ... ... partnership with healthcare talent acquisition startup, HireNurses, on the eve of National Nurses ... for job seeking nurses and healthcare employers. With their enrollment into the Talent Tech ...
(Date:5/5/2016)... ... May 05, 2016 , ... Chronic stress can have a silent, yet dangerous, ... the immune system and increase inflammation, both of which raise the risk of heart ... heart disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also can lead to ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... finalists and winners Tuesday evening, May 3, at the 2016 ISE® Central Executive ... Scott Pettigrew, Vice President and Chief Security Officer of HMS, was selected as ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 4, 2016 According to market research ... Demand Forecast to 2022 - Industry Insights by Slice Type ... and Others)" by P&S Market Research, the global computed ... and it is expected to grow at a CAGR of ... type segment is expected to witness the faster growth, CAGR ...
(Date:5/4/2016)... Research and Markets has ... Myeloma Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... Highlights 2016, provides comprehensive insights into Multiple ... Myeloma market valuations and forecast, Multiple Myeloma ...
(Date:5/4/2016)... Research and Markets has ... lymphocytic Leukemia Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Lymphocytic Leukemia epidemiology, Acute Lymphocytic Leukemia ...
Breaking Medicine Technology: